Clinical Trial Update: Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures [Phase 3]

View source ↗

Summary

Results from a Phase 3 long-term safety study of lacosamide in adults with partial-onset seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• lacosamide (Vimpat) (lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Partial Epilepsies, Partial Onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2011-07-15